Raymond James Downgrades Allscripts (MDRX) to Market Perform
More News related to MDRX
- NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum
- Chicago Healthcare Entrepreneur Glen Tullman Donates $1 Million to Support JDRF's Artificial Pancreas Project
- Raymond James Downgrades Allscripts (MDRX) to Market Perform
- NASDAQ OMX and Leerink Swann to Co-Host Healthcare Industry Forum
- Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management
More News related to Downgrades
- SanDisk (SNDK) Falls After Toshiba Said No Buyout
- Cramer Gives a "Don't Buy" on First Solar (FSLR)
- CNBC May Cut As Many As 80 Employees Today
- Layoffs Mount: AT&T, DuPont, Viacom Announce Job Cuts
- Perma-Bull on Apple (AAPL) Cuts Price Target to $235
Raymond James downgrades Allscripts (Nasdaq: MDRX) from Strong Buy to Market Perform.
Allscripts Healthcare Solutions, Inc. provides clinical software, connectivity, and information solutions for physicians in the United States.
Related Categories
DowngradesStocks Mentioned
+0.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
